BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38698855)

  • 1. Interleukin-2 is required for NKp30-dependent NK cell cytotoxicity by preferentially regulating NKp30 expression.
    Kim N; Yi E; Lee E; Park HJ; Kim HS
    Front Immunol; 2024; 15():1388018. PubMed ID: 38698855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NKP30-B7-H6 Interaction Aggravates Hepatocyte Damage through Up-Regulation of Interleukin-32 Expression in Hepatitis B Virus-Related Acute-On-Chronic Liver Failure.
    Zou Y; Bao J; Pan X; Lu Y; Liao S; Wang X; Wang G; Lin D
    PLoS One; 2015; 10(8):e0134568. PubMed ID: 26241657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secreted Ligands of the NK Cell Receptor NKp30: B7-H6 Is in Contrast to BAG6 Only Marginally Released via Extracellular Vesicles.
    Ponath V; Hoffmann N; Bergmann L; Mäder C; Alashkar Alhamwe B; Preußer C; Pogge von Strandmann E
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity Maturation of B7-H6 Translates into Enhanced NK Cell-Mediated Tumor Cell Lysis and Improved Proinflammatory Cytokine Release of Bispecific Immunoligands via NKp30 Engagement.
    Pekar L; Klausz K; Busch M; Valldorf B; Kolmar H; Wesch D; Oberg HH; Krohn S; Boje AS; Gehlert CL; Toleikis L; Krah S; Gupta T; Rabinovich B; Zielonka S; Peipp M
    J Immunol; 2021 Jan; 206(1):225-236. PubMed ID: 33268483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of NKp30, NKp46 and DNAM-1 activating receptors on resting and IL-2 activated NK cells from healthy donors according to CMV-serostatus and age.
    Campos C; López N; Pera A; Gordillo JJ; Hassouneh F; Tarazona R; Solana R
    Biogerontology; 2015 Oct; 16(5):671-83. PubMed ID: 25991472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression, crystallization and X-ray diffraction analysis of a complex between B7-H6, a tumor cell ligand for the natural cytotoxicity receptor NKp30, and an inhibitory antibody.
    Xu X; Li Y; Gauthier L; Chen Q; Vivier E; Mariuzza RA
    Acta Crystallogr F Struct Biol Commun; 2015 Jun; 71(Pt 6):697-701. PubMed ID: 26057798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mimicking an induced self phenotype by coating lymphomas with the NKp30 ligand B7-H6 promotes NK cell cytotoxicity.
    Kellner C; Maurer T; Hallack D; Repp R; van de Winkel JG; Parren PW; Valerius T; Humpe A; Gramatzki M; Peipp M
    J Immunol; 2012 Nov; 189(10):5037-46. PubMed ID: 23066150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B7-H6/NKp30 interaction: a mechanism of alerting NK cells against tumors.
    Kaifu T; Escalière B; Gastinel LN; Vivier E; Baratin M
    Cell Mol Life Sci; 2011 Nov; 68(21):3531-9. PubMed ID: 21877119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction.
    Fauriat C; Just-Landi S; Mallet F; Arnoulet C; Sainty D; Olive D; Costello RT
    Blood; 2007 Jan; 109(1):323-30. PubMed ID: 16940427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells.
    Fiegler N; Textor S; Arnold A; Rölle A; Oehme I; Breuhahn K; Moldenhauer G; Witzens-Harig M; Cerwenka A
    Blood; 2013 Aug; 122(5):684-93. PubMed ID: 23801635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic and xenogeneic anti-tumor effect of callithrix jacchus natural killer cells is dependent on NKp30 and B7-H6 interaction.
    Müller T; Schlahsa L; Zhang HJ; Skaik Y; Eiz-Vesper B; Immenschuh S; Blasczyk R; Figueiredo C
    J Biol Regul Homeost Agents; 2014; 28(2):183-93. PubMed ID: 25001651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homo-oligomerization of the activating natural killer cell receptor NKp30 ectodomain increases its binding affinity for cellular ligands.
    Herrmann J; Berberich H; Hartmann J; Beyer S; Davies K; Koch J
    J Biol Chem; 2014 Jan; 289(2):765-77. PubMed ID: 24275655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions.
    Garcia-Iglesias T; Del Toro-Arreola A; Albarran-Somoza B; Del Toro-Arreola S; Sanchez-Hernandez PE; Ramirez-Dueñas MG; Balderas-Peña LM; Bravo-Cuellar A; Ortiz-Lazareno PC; Daneri-Navarro A
    BMC Cancer; 2009 Jun; 9():186. PubMed ID: 19531227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin.
    Jarahian M; Fiedler M; Cohnen A; Djandji D; Hämmerling GJ; Gati C; Cerwenka A; Turner PC; Moyer RW; Watzl C; Hengel H; Momburg F
    PLoS Pathog; 2011 Aug; 7(8):e1002195. PubMed ID: 21901096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation.
    Vacca P; Martini S; Garelli V; Passalacqua G; Moretta L; Mingari MC
    Eur J Immunol; 2013 Feb; 43(2):550-61. PubMed ID: 23192659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK cell-mediated lysis of autologous antigen-presenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46.
    Spaggiari GM; Carosio R; Pende D; Marcenaro S; Rivera P; Zocchi MR; Moretta L; Poggi A
    Eur J Immunol; 2001 Jun; 31(6):1656-65. PubMed ID: 11385609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B7H6-derived peptides trigger TNF-α-dependent immunostimulatory activity of lymphocytic NK92-MI cells.
    Phillips M; Romeo F; Bitsaktsis C; Sabatino D
    Biopolymers; 2016 Sep; 106(5):658-72. PubMed ID: 27216712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity.
    Peipp M; Derer S; Lohse S; Staudinger M; Klausz K; Valerius T; Gramatzki M; Kellner C
    Oncotarget; 2015 Oct; 6(31):32075-88. PubMed ID: 26392331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of CD158 and NKG2A Inhibitory Receptors and Underexpression of NKG2D and NKp46 Activating Receptors on NK Cells in Acute Myeloid Leukemia.
    Sandoval-Borrego D; Moreno-Lafont MC; Vazquez-Sanchez EA; Gutierrez-Hoya A; López-Santiago R; Montiel-Cervantes LA; Ramírez-Saldaña M; Vela-Ojeda J
    Arch Med Res; 2016 Jan; 47(1):55-64. PubMed ID: 26876298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Important role for NKp30 in synapse formation and activation of NK cells.
    Wang H; Zheng X; Wei H; Tian Z; Sun R
    Immunol Invest; 2012; 41(4):367-81. PubMed ID: 22221078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.